Arbutus Biopharma Corporation Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
MORGAN STANLEY | 02/14/2025 | 22.59 M | $73.86 M | 4.05% | 11.95% |
WHITEFORT CAPITAL MANAGEMENT, LP | 02/14/2025 | 13.24 M | $43.30 M | 2.91% | 7.01% |
BLACKROCK, INC. | 02/07/2025 | 12.94 M | $42.31 M | 5.88% | 6.85% |
VANGUARD GROUP INC | 02/11/2025 | 8.98 M | $29.37 M | 0.70% | 4.75% |
TWO SEAS CAPITAL LP | 02/18/2025 | 8.74 M | $28.58 M | 4.22% | 4.62% |
STATE STREET CORP | 02/14/2025 | 5.03 M | $16.44 M | 14.06% | 2.66% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.48 M | $11.39 M | 0.97% | 1.84% |
BLACKBARN CAPITAL PARTNERS LP | 02/14/2025 | 2.34 M | $7.66 M | 13.08% | 1.24% |
RUBRIC CAPITAL MANAGEMENT LP | 02/14/2025 | 1.68 M | $5.50 M | 0.00% | 0.89% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.65 M | $5.40 M | -43.09% | 0.87% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 1.55 M | $5.08 M | -25.58% | 0.82% |
02/12/2025 | 1.46 M | $4.77 M | 100.00% | 0.77% | |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 1.36 M | $5.24 M | -0.72% | 0.72% |
NORTHERN TRUST CORP | 02/14/2025 | 1.33 M | $4.35 M | 8.32% | 0.70% |
FOURWORLD CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.23 M | $4.01 M | -58.73% | 0.65% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.22 M | $4.00 M | 0.82% | 0.65% |
HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 1.11 M | $3.64 M | 8.01% | 0.59% |
WOODLINE PARTNERS LP | 02/14/2025 | 971.63 K | $3.18 M | 45.42% | 0.51% |
JPMORGAN CHASE & CO | 02/12/2025 | 896.26 K | $2.93 M | 900.44% | 0.47% |
SABA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 887.99 K | $2.90 M | 31.28% | 0.47% |
CORBIN CAPITAL PARTNERS, L.P. | 02/11/2025 | 682.49 K | $2.23 M | -20.02% | 0.36% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 531.88 K | $1.74 M | -5.09% | 0.28% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 513.30 K | $1.68 M | 3.32% | 0.27% |
BANK OF MONTREAL /CAN/ | 02/13/2025 | 455.88 K | $1.49 M | 3.54% | 0.24% |
FREESTONE CAPITAL HOLDINGS, LLC | 02/06/2025 | 442.50 K | $1.45 M | -0.16% | 0.23% |
KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 420.71 K | $1.38 M | 0.19% | 0.22% |
QUINN OPPORTUNITY PARTNERS LLC | 02/13/2025 | 404.88 K | $1.32 M | 72.19% | 0.21% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 390.34 K | $1.28 M | 129.22% | 0.21% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 361.30 K | $1.18 M | 90.76% | 0.19% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 353.37 K | $1.16 M | 0.23% | 0.19% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 343.03 K | $1.12 M | 36.69% | 0.18% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 313.31 K | $1.02 M | 0.00% | 0.17% |
BARCLAYS PLC | 02/13/2025 | 298.25 K | $975.00 K | 9.64% | 0.16% |
04/10/2025 | 278.44 K | $910.49 K | 0.00% | 0.15% | |
CITADEL ADVISORS LLC | 02/14/2025 | 277.56 K | $907.62 K | -54.33% | 0.15% |
SWISS NATIONAL BANK | 02/10/2025 | 276.30 K | $903.50 K | 0.00% | 0.15% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 248.00 K | $810.95 K | -19.05% | 0.13% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 244.60 K | $799.84 K | -34.21% | 0.13% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 202.54 K | $662.31 K | 100.00% | 0.11% |
RHUMBLINE ADVISERS | 01/30/2025 | 188.60 K | $616.71 K | 6.03% | 0.10% |
CITIGROUP INC | 02/12/2025 | 187.72 K | $613.84 K | 72.14% | 0.10% |
SQUAREPOINT OPS LLC | 02/14/2025 | 184.50 K | $603.32 K | 100.00% | 0.10% |
SQUAREPOINT OPS LLC | 02/14/2025 | 178.10 K | $582.38 K | 174.81% | 0.09% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 175.00 K | $572.25 K | 100.00% | 0.09% |
DEUTSCHE BANK AG\ | 02/14/2025 | 171.77 K | $561.68 K | 77.90% | 0.09% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 162.28 K | $530.65 K | -73.50% | 0.09% |
LMR PARTNERS LLP | 02/14/2025 | 158.25 K | $517.47 K | -19.68% | 0.08% |
CITIGROUP INC | 02/12/2025 | 150.00 K | $490.50 K | -52.74% | 0.08% |
RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 146.80 K | $480.05 K | 27.63% | 0.08% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 03/18/2025 | 132.76 K | $434.12 K | -1.13% | 0.07% |
Arbutus Biopharma Corporation institutional Ownership - FAQ's
During the previous two years, 155 institutional investors and hedge funds held shares of Arbutus Biopharma Corporation. The most heavily invested institutionals were:
Ballentine Partners, LLC: 0
MORGAN STANLEY: 22.59 M
Whitefort Capital Management, LP: 13.24 M
VANGUARD GROUP INC: 8.98 M
Two Seas Capital LP: 8.74 M
STATE STREET CORP: 5.03 M
55.04% of Arbutus Biopharma Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 102.45 M shares in the last 24 months. This purchase volume represents approximately $339.11 M in transactions.